Horizon Therapeutics Public Ltd Co Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Horizon Therapeutics Public Ltd Co quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q2 2023.
Horizon Therapeutics Public Ltd Co Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$7.59M, a 68.1% increase year-over-year.
Horizon Therapeutics Public Ltd Co Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was -$69.5M, a 24.2% increase year-over-year.
Horizon Therapeutics Public Ltd Co annual Nonoperating Income (Expense) for 2022 was -$90.5M, a 12.7% decline from 2021.
Horizon Therapeutics Public Ltd Co annual Nonoperating Income (Expense) for 2021 was -$80.3M, a 9.14% increase from 2020.
Horizon Therapeutics Public Ltd Co annual Nonoperating Income (Expense) for 2020 was -$88.4M, a 39.8% increase from 2019.

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Quarterly (USD)

Nonoperating Income (Expense), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	-$69.5M	-$7.59M	+$16.2M	+68.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	-$85.7M	-$16.8M	+$4.79M	+22.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-03
Q4 2022	-$90.5M	-$19.6M	+$2.43M	+11%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-01
Q3 2022	-$92.9M	-$25.5M	-$1.22M	-5.03%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-02
Q2 2022	-$91.7M	-$23.8M	-$888K	-3.88%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	-$90.8M	-$21.6M	-$10.5M	-94.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-03
Q4 2021	-$80.3M	-$22M	-$11.5M	-109%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-01
Q3 2021	-$68.8M	-$24.3M	+$2.52M	+9.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	-$71.3M	-$22.9M	+$12M	+34.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	-$83.3M	-$11.1M	+$5.04M	+31.3%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	-$88.4M	-$10.5M	+$7.27M	+40.9%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	-$95.7M	-$26.8M	+$34.1M	+56%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	-$130M	-$34.9M	+$197K	+0.56%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	-$130M	-$16.1M	+$16.9M	+51.1%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	-$147M	-$17.8M	+$12.1M	+40.4%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	-$159M	-$60.9M	-$30.9M	-103%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-02
Q2 2019	-$128M	-$35.1M	-$4.42M	-14.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	-$124M	-$33M	-$2.58M	-8.47%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-06
Q4 2018	-$121M	-$29.9M	+$60K	+0.2%	Oct 1, 2018	Dec 31, 2018	10-K	2020-02-26
Q3 2018	-$121M	-$30.1M	+$974K	+3.14%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-06
Q2 2018	-$122M	-$30.7M	-$5.05M	-19.7%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018	-$117M	-$30.4M	+$2.33M	+7.11%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	-$119M	-$29.9M	-$195K	-0.66%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-26
Q3 2017	-$119M	-$31M	-$18.7M	-152%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07
Q2 2017	-$100M	-$25.6M	-$6.4M	-33.3%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-08
Q1 2017	-$94M	-$32.7M	-$13.1M	-66.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-09
Q4 2016	-$80.9M	-$29.7M	+$19.8M	+39.9%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-27
Q3 2016	-$101M	-$12.3M	+$8.18M	+40%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-06
Q2 2016	-$109M	-$19.2M	+$76.5M	+79.9%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-07
Q1 2016	-$185M	-$19.6M	+$2.76M	+12.3%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-08
Q4 2015	-$188M	-$49.5M	-$6.06M	-14%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-28
Q3 2015	-$182M	-$20.5M	-$31.5M	-286%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-07
Q2 2015	-$151M	-$95.7M	-$75.9M	-384%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-08
Q1 2015	-$74.7M	-$22.4M	+$187M	+89.3%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-09
Q4 2014	-$261M	-$43.4M	+$53.8M	+55.3%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-27
Q3 2014	-$315M	$11M	+$13.5M		Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-06
Q2 2014	-$329M	-$19.8M	-$16.8M	-562%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-07
Q1 2014	-$312M	-$209M	-$204M	-4535%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-08
Q4 2013	-$107M	-$97.3M	-$94.7M	-3581%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-29
Q3 2013	-$12.6M	-$2.48M	+$268K	+9.74%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-06
Q2 2013	-$12.9M	-$2.99M	+$1.61M	+35%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-07
Q1 2013	-$14.5M	-$4.51M	-$406K	-9.9%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-09
Q4 2012	-$14.1M	-$2.64M	-$1.03M	-63.6%	Oct 1, 2012	Dec 31, 2012	10-K/A	2015-03-02
Q3 2012	-$13.1M	-$2.75M	-$998K	-56.9%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-08
Q2 2012	-$12.1M	-$4.6M	-$1.52M	-49.5%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-09
Q1 2012	-$10.5M	-$4.1M	-$3.24M	-375%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-10
Q4 2011	-$7.31M	-$1.62M			Oct 1, 2011	Dec 31, 2011	10-K	2014-03-13
Q3 2011		-$1.75M			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-13
Q2 2011		-$3.08M			Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-10
Q1 2011		-$863K			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.